ADJUVANT Trial of Gefitinib Versus Chemotherapy in Resected EGFR-Mutations Non-Small Cell Lung Cancer

IASLC Workshop in Lung Cancer Clinical Research

ELCC 2017 Unveils New Research Regarding Screening, Immunotherapy, Treatment Planning, and More

Clinical Labeling in Medicinal Products: An Interview With Dr. David Planchard About the Effects of BRAF Mutations on Non-small Cell Lung Cancer Outcomes and Therapeutic Selection

2017 ASCO Annual Meeting

The CRISPR-Cas9 Toolkit: Moving From Bench to Bedside

Best of the IASLC 17th World Conference on Lung Cancer in Lima, Peru, February 2017

IASLC Small Cell Lung Cancer Workshop

17th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting

Societies Join Forces to Host Seventh European Lung Cancer Conference

First Congress of Interventional Pulmonology & EBUS and the XI South American Bronchology Congresses

PD-L1 Blueprint Project